FR2319346A1 - Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole - Google Patents

Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole

Info

Publication number
FR2319346A1
FR2319346A1 FR7623355A FR7623355A FR2319346A1 FR 2319346 A1 FR2319346 A1 FR 2319346A1 FR 7623355 A FR7623355 A FR 7623355A FR 7623355 A FR7623355 A FR 7623355A FR 2319346 A1 FR2319346 A1 FR 2319346A1
Authority
FR
France
Prior art keywords
antiinflammatory
nonulcerogenic
compsns
benz
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7623355A
Other languages
English (en)
Other versions
FR2319346B1 (fr
Inventor
Robert Bruce Clark
Sergio Henrique Ferreira
Nariman Bomanshaw Mehta
Peter Brian Thorogood
Ralph Vinegar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2319346A1 publication Critical patent/FR2319346A1/fr
Application granted granted Critical
Publication of FR2319346B1 publication Critical patent/FR2319346B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
FR7623355A 1975-07-31 1976-07-30 Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole Granted FR2319346A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200475 1975-07-31
GB3200575 1975-07-31
GB2718476 1976-06-30

Publications (2)

Publication Number Publication Date
FR2319346A1 true FR2319346A1 (fr) 1977-02-25
FR2319346B1 FR2319346B1 (fr) 1979-05-25

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7623355A Granted FR2319346A1 (fr) 1975-07-31 1976-07-30 Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole

Country Status (10)

Country Link
JP (1) JPS5218831A (fr)
AU (1) AU1643776A (fr)
DE (1) DE2634409A1 (fr)
DK (1) DK345676A (fr)
FR (1) FR2319346A1 (fr)
IL (1) IL50174A0 (fr)
LU (1) LU75513A1 (fr)
NL (1) NL7608503A (fr)
NZ (1) NZ181635A (fr)
SE (1) SE7608611L (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045200A1 (fr) * 1980-07-28 1982-02-03 The Upjohn Company Benzimidazoles et leur application pharmaceutique
FR2488136A1 (fr) * 1980-08-05 1982-02-12 Italfarmaco Spa Composition pharmaceutique a base de salicylate d'imidazole
EP0270316A2 (fr) * 1986-12-04 1988-06-08 Pfizer Inc. Compositions topiques contenant des imidazoles 1-substitués et des agents non-steroides anti-inflammatoires pour le traitement de l'acné
EP0449426A1 (fr) * 1990-02-26 1991-10-02 Byrne Rynne Holdings Limited Composition pharmaceutique

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
UNLISTED DRUGS, 24, P.9C 1972 "LIPIDAZIL") *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045200A1 (fr) * 1980-07-28 1982-02-03 The Upjohn Company Benzimidazoles et leur application pharmaceutique
FR2488136A1 (fr) * 1980-08-05 1982-02-12 Italfarmaco Spa Composition pharmaceutique a base de salicylate d'imidazole
EP0270316A2 (fr) * 1986-12-04 1988-06-08 Pfizer Inc. Compositions topiques contenant des imidazoles 1-substitués et des agents non-steroides anti-inflammatoires pour le traitement de l'acné
EP0270316A3 (fr) * 1986-12-04 1989-12-06 Pfizer Inc. Compositions topiques contenant des imidazoles 1-substitués et des agents non-steroides anti-inflammatoires pour le traitement de l'acné
EP0449426A1 (fr) * 1990-02-26 1991-10-02 Byrne Rynne Holdings Limited Composition pharmaceutique
US5156849A (en) * 1990-02-26 1992-10-20 Byrne Rynne Holdings Limited Pharmaceutical composition

Also Published As

Publication number Publication date
FR2319346B1 (fr) 1979-05-25
NZ181635A (en) 1978-09-25
DE2634409A1 (de) 1977-02-17
DK345676A (da) 1977-02-01
JPS5218831A (en) 1977-02-12
LU75513A1 (fr) 1977-04-15
SE7608611L (sv) 1977-02-01
IL50174A0 (en) 1976-09-30
NL7608503A (nl) 1977-02-02
AU1643776A (en) 1978-02-02

Similar Documents

Publication Publication Date Title
FR2319346A1 (fr) Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole
Derelanko et al. Carbenoxolone sodium protects rat gastric mucosa against ethanol-induced necrosis
SE7413548L (fr)
GB1246141A (en) Improvements in or relating to -hydroxylproline derivatives
ES450897A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona.
GB1069969A (en) Morphine and codeine derivatives
HUT39605A (en) Process for producing improved antiinflammation preparation
JPS523178A (en) Fire-resistant electric wires
IE35569L (en) 2-phenyl-5-aminodiazole derivatives
JPS535193A (en) 2-alkyl-7-substituted-2 or 3-cephem-4-carboxlic acids, their salts and their preparation
GB902659A (en) A process for the production of a derivative of thebaine
FR2318649A1 (fr) Medicament pour le traitement des rhumatismes et cancers
FR2073254A2 (en) Gum guar stabilised suspensions - of insoluble medicaments for treati gastrointestinal disorders
JPS51128907A (en) Process for preparing the salts of glyceryl malate
ES385183A1 (es) Procedimiento para la preparacion de nuevos agentes de con-traste de rayos x.
GB1351853A (en) Salicylate derivative
SE8303539D0 (sv) Polyenverbindungen
JPS51136052A (en) Heat pipe type thermal organ
GB1239266A (fr)
JPS539758A (en) Preparation of santonin derivatives
JPS51149787A (en) X-ray mashine for dental surgery
JPS5210207A (en) Process for preparation of high purity pulenol
ES444959A1 (es) Procedimiento para la obtencion de bifenilileteres.
JPS521603A (en) Improvement of a tube pump
FR2302087A1 (fr) Nouveaux derives de l'acide phenylbutyrique et leur procede de preparation

Legal Events

Date Code Title Description
ST Notification of lapse